Follow
Kin Kui Lai
Kin Kui Lai
National Cancer Institute
Verified email at nih.gov
Title
Cited by
Cited by
Year
Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
G Shi, AD Kenney, E Kudryashova, A Zani, L Zhang, KK Lai, ...
The EMBO journal 40 (3), e106501, 2021
2032021
Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor
JFW Chan, KKH Chik, S Yuan, CCY Yip, Z Zhu, KM Tee, JOL Tsang, ...
Antiviral research 141, 29-37, 2017
1312017
Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response
NN Cheung, KK Lai, J Dai, KH Kok, H Chen, KH Chan, KY Yuen, ...
Journal of General Virology 98 (5), 946-954, 2017
692017
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
G Shi, AI Chiramel, T Li, KK Lai, AD Kenney, A Zani, AC Eddy, S Majdoul, ...
The Journal of Clinical Investigation 132 (24), 2022
312022
Identification of novel fusion inhibitors of influenza A virus by chemical genetics
KK Lai, NN Cheung, F Yang, J Dai, L Liu, Z Chen, KH Sze, H Chen, ...
Journal of virology 90 (5), 2690-2701, 2016
302016
Discovery of a novel specific inhibitor targeting influenza A virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle
F Yang, B Pang, KK Lai, NN Cheung, J Dai, W Zhang, J Zhang, KH Chan, ...
Journal of virology 95 (9), 10.1128/jvi. 01432-20, 2021
172021
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry
SA Leonhardt, MD Purdy, JR Grover, Z Yang, S Poulos, WE McIntire, ...
Nature Communications 14 (1), 4368, 2023
62023
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
G Shi, T Li, KK Lai, RF Johnson, JW Yewdell, AA Compton
Nature Communications 15 (1), 889, 2024
52024
Restriction of influenza A virus by SERINC5
KK Lai, JB Munro, G Shi, S Majdoul, AA Compton, A Rein
MBio 13 (6), e02923-22, 2022
52022
CryoEM structures of the human HIV-1 restriction factor SERINC3 and function as a lipid transporter
SA Leonhardt, MD Purdy, JR Grover, Z Yang, S Poulos, WE McIntire, ...
bioRxiv, 2022.07. 06.498924, 2022
42022
Essential functions of Inositol hexakisphosphate (IP6) in Murine Leukemia Virus replication
B Biswas, KK Lai, H Bracey, SAK Datta, D Harvin, GA Sowd, C Aiken, ...
bioRxiv, 2024.02. 27.581940, 2024
2024
The extracellular tail of IFITM3 promotes SARS-CoV-2 entry into cells and is diversifying in primates
AA Compton, T Li, G Shi, KK Lai, N Mak, A Jolley, S Speaks, JS Yount, ...
The Journal of Immunology 210 (1_Supplement), 71.32-71.32, 2023
2023
OMICRON SPIKE ENDOWS SARS-CoV-2 WITH ENHANCED INFECTIVITY IN NASAL EPITHELIA
G Shi, T Li, K Lai, J Yewdell, AA Compton
Topics in Antiviral Medicine, 95-95, 2023
2023
Correction for Lai et al.,“Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics”
KK Lai, NN Cheung, F Yang, J Dai, L Liu, Z Chen, KH Sze, H Chen, ...
Journal of Virology 95 (15), 10.1128/jvi. 00665-21, 2021
2021
Repurposing novobiocin as an antiviral treatment option for yellow fever virus infection
JFW Chan, S Yuan, KKH CHIK, CS Chan, KM Poon, CY Yip, KM Tee, ...
34th ASM Clinical Virology Symposium, 2018
2018
Repurposing novobiocin as a flavivirus protease inhibitor
JFW Chan, S Yuan, KKH Chik, CY Yip, KM Tee, KK Lai, RYT Kao, ...
Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), 2018
2018
Discovery and characterization of broad-spectrum entry inhibitors of coronaviruses
K Lai
HKU Theses Online (HKUTO), 2018
2018
Identification and characterization of a novel fusion inhibitor of influenza A virus
K Lai
HKU Theses Online (HKUTO), 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–18